Inventor · disambiguated record
Matthew Robert Sender
Also filed as: SENDER MATTHEW ROBERT
0 granted patents·6 pending applications·0 citations·filing 2022–2024
Files withGLAXOSMITHKLINE IP DEV LTD6
Top patents by PatentIndex Score
6 records- 0164US2025154288A1Cytotoxicity targeting chimeras for c-c chemokine receptor 2-expressing cellsGLAXOSMITHKLINE IP DEV LTD·Filed 2024·Application pending·0 cites
- 0264US2025057827A1Cytotoxicity targeting chimeras for prostate specific membrane antigen-expressing cellsGLAXOSMITHKLINE IP DEV LTD·Filed 2024·Application pending·0 cites
- 0363US2025049932A1Cytotoxicity targeting chimeras for folate receptor-expressing cellsGLAXOSMITHKLINE IP DEV LTD·Filed 2024·Application pending·0 cites
- 0463US2025064947A1Cytotoxicity targeting chimeras for fibroblast activation protein-expressing cellsGLAXOSMITHKLINE IP DEV LTD·Filed 2024·Application pending·0 cites
- 0561US2025057958A1Cytotoxicity targeting chimeras for ccr2-expressing cellsGLAXOSMITHKLINE IP DEV LTD·Filed 2024·Application pending·0 cites
- 0652US2025136722A1Cytotoxicity targeting chimerasGLAXOSMITHKLINE IP DEV LTD·Filed 2022·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Matthew Robert Sender files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →